Axsome reports mixed results for Alzheimer's agitation drug - MSN
Axsome Therapeutics (NASDAQ:AXSM) stock fell 12% Monday after the company reported mixed Phase 3 results for its drug AXS-05, or dextromethorphan-bupropion, in the treatment of …
OFF
Axsome Reports Mixed Results For Alzheimer's Agitation Drug - MSN
2 weeks from now
Axsome Therapeutics (NASDAQ:AXSM) stock fell 12% Monday after the company reported mixed Phase 3 results for its drug AXS-05, or dextromethorphan-bupropion, in the treatment of …
msn.com
OFF
Alzheimer’s Drug Study Yields Mixed Results. Wall Street Still
2 weeks from now
One of the few popular drug stocks not tied to weight loss, Axsome Therapeutics sank 13% when the company reported mixed outcomes in two Alzheimer’s studies on Monday. In one study, …
msn.com
OFF
Axsome Reports Mixed Results For Alzheimer's Agitation Drug
2 weeks from now
Dec 30, 2024 · Axsome Therapeutics (AXSM) stock fell 12% Monday after the company reported mixed Phase 3 results for its drug AXS-05 in the treatment of agitation in Alzheimer's disease …
seekingalpha.com
OFF
Axsome To Seek Approval For Alzheimer's-related Agitation Drug
2 weeks from now
But shares of the New York-based drug developer fell more than 10%, as the treatment did not show statistically significant results in one of the studies. Axsome tested the drug, AXS-05, in …
msn.com
Install CouponFollow Extension on Chrome
Install the CouponFollow extension to search for discount codes when shopping the fastest!
Install CouponFollow Chrome Extension
Listing Store by Characters
